Home Tags Eisai
Biogen Explodes on Game-Changing Alzheimer’s News
Shares of Biogen (BBIB) are up more than $93 in pre-market. All after a substantial announcement on its Alzheimer’s drug study, in partnership with Eisai. In...
Subscribe to our mailing list and get interesting stuff and updates to your email inbox.